Accordingly, individual risks of decease hazard ratios for ACSL3, NID1, and RETN high‐expressing NSCLC patients were 2.93 (95% CI: 1.5–5.73), P = 0.011; 2.2 (95% CI: 1.32–3.64), P = 0.04, and 3.23 (95% CI: 1.61–6.49), P = 0.004, respectively. Here, ACSL3 is linked to non-small cell lung carcinoma.